Technology
100 Most Popular
Most Popular Under $25

Viking Therapeutics

$7.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-3.53%) Today
-$0.02 (-0.25%) As of 5:12 PM EDT after-hours

Why Robinhood?

You can buy or sell VKTX and other stocks, options, ETFs, and crypto commission-free!

About VKTX

Viking Therapeutics, Inc. Common Stock, also called Viking Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Read More The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Employees
15
Headquarters
San Diego, California
Founded
2012
Market Cap
592.07M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.12M
High Today
$8.27
Low Today
$7.91
Open Price
$8.25
Volume
1.31M
52 Week High
$24.00
52 Week Low
$6.97

Collections

Technology
100 Most Popular
Most Popular Under $25
Health
Biotechnology
Medical
Therapy
Biopharmaceutical

VKTX Earnings

-$0.18
-$0.14
-$0.11
-$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.